Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear oncology 1984.

S M Larson, J A Carrasquillo

    Seminars in Nuclear Medicine
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Nuclear oncology advancements, using monoclonal antibodies and positron emission tomography, offer new ways to diagnose and treat solid tumors. The same radiolabeled antibody preparation may soon be used for both diagnosis and therapy.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Extrahepatic visualization in the distribution of falciform artery in posttreatment Bremsstrahlung images after radioembolization with (90)Y microspheres.

    Revista espanola de medicina nuclear e imagen molecular·2014
    Same author

    Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT.

    Revista espanola de medicina nuclear e imagen molecular·2013
    Same author

    Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.

    The Journal of clinical endocrinology and metabolism·2013
    Same author

    Evaluation of elemental cadmium as a marker for environmental tobacco smoke.

    Environmental science & technology·2012
    Same author

    Chemically treated activated carbon cloths for removal of volatile organic carbons from gas streams: evidence for enhanced physical adsorption.

    Environmental science & technology·2011
    Same journal

    Letter from the Editors.

    Seminars in nuclear medicine·2026
    Same journal

    Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.

    Seminars in nuclear medicine·2026
    Same journal

    The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.

    Seminars in nuclear medicine·2026
    Same journal

    Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

    Seminars in nuclear medicine·2026
    Same journal

    <sup>18</sup>F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.

    Seminars in nuclear medicine·2026
    Same journal

    Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.

    Seminars in nuclear medicine·2026
    See all related articles

    Area of Science:

    • Oncology
    • Nuclear Medicine
    • Immunotherapy

    Background:

    • Nuclear medicine methods are expanding in clinical oncology.
    • Monoclonal antibodies and positron emission tomography (PET) are key technologies.

    Purpose of the Study:

    • To explore new applications of nuclear medicine in cancer management.
    • To highlight the potential of combined diagnostic and therapeutic approaches.

    Main Methods:

    • Utilizing monoclonal antibodies for targeted delivery.
    • Employing positron emission tomography for metabolic assessment (glucose metabolism).

    Main Results:

    • New developments promise broader applications in patient management.
    • Potential for diagnosing and treating solid tumors with a single agent.

    Conclusions:

    • Radiolabeled monoclonal antibodies combined with PET show significant promise.
    • A single pharmaceutical preparation may serve dual diagnostic and therapeutic roles in oncology.